Hemophilia and prophylaxis

Pediatric Blood and Cancer

Volumn 60, Issue SUPPL.1, 2013, Pages

  Ljung, Rolf ^a,b  

^a Departments of Pediatrics   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Factor IX; Factor VIII; Hemophilia A; Hemophilia B

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ARTHROPATHY; BRAIN HEMORRHAGE; DISEASE PREDISPOSITION; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEMARTHROSIS; HEMOPHILIA A; HEMOPHILIA B; HUMAN; MEDICAL ETHICS; PERSONALIZED MEDICINE; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SWEDEN; TREATMENT DURATION;

BLOOD COAGULATION; CHILD; FACTOR IX; FACTOR VIII; HEMARTHROSIS; HEMOPHILIA A; HEMOPHILIA B; HUMANS; TREATMENT OUTCOME;

EID: 84869211465     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24340     Document Type: Review

References (25)

1. Nilsson IM, Berntorp E, Lofqvist T, et al. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 1992; 232: 25-32.
2. Blomback M, Nilsson IM. Treatment of hemophilia A with human antihemophilic globulin. Acta Med Scand 1958; 161: 301-321.
3. Astermark J, Petrini P, Tengborn L, et al. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized. Br J Haematol 1999; 105: 1109-1113.
4. Van Creveld S. Prophylaxis of joint hemorrhages in hemophilia. Acta Haematol 1969; 41: 206-214.
5. van den Berg HM, Fischer K, Mauser-Bunschoten EP, et al. Long-term outcome of individualized prophylactic treatment of children with severe haemophilia. Br J Haematol 2001; 112: 561-565.
6. Aledort LM, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med 1994; 236: 391-399.
7. Steen Carlsson K, Hojgard S, Glomstein A, et al. On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: Differences in treatment characteristics and outcome. Haemophilia 2003; 9: 555-566.
8. Fischer K, van der Bom JG, Molho P, et al. Prophylactic versus on-demand treatment strategies for severe haemophilia: A comparison of costs and long-term outcome. Haemophilia 2002; 8: 745-752.
9. Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-544.
10. Ljung RC. Intracranial haemorrhage in haemophilia A and B. Br J Haematol 2008; 140: 378-384.
11. Stieltjes N, Calvez T, Demiguel V, et al. Intracranial haemorrhages in French haemophilia patients (1991-2001): Clinical presentation, management and prognosis factors for death. Haemophilia 2005; 11: 452-458.
12. Traivaree C, Blanchette V, Armstrong D, et al. Intracranial bleeding in haemophilia beyond the neonatal period-The role of CT imaging in suspected intracranial bleeding. Haemophilia 2007; 13: 552-559.
13. Antunes SV, Vicari P, Cavalheiro S, et al. Intracranial haemorrhage among a population of haemophilic patients in Brazil. Haemophilia 2003; 9: 573-577.
14. Revel-Vilk S, Golomb MR, Achonu C, et al. Effect of intracranial bleeds on the health and quality of life of boys with hemophilia. J Pediatr 2004; 144: 490-495.
15. Fischer K, Astermark J, van der Bom JG, et al. Prophylactic treatment for severe haemophilia: Comparison of an intermediate-dose to a high-dose regimen. Haemophilia 2002; 8: 753-760.
16. Feldman BM, Pai M, Rivard GE, et al. Tailored prophylaxis in severe hemophilia A: Interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study. J Thromb Haemost 2006; 4: 1228-1236.
17. Lindvall K, Astermark J, Björkman S, et al. Daily dosing prophylaxis for hameophilia: A randomized crossover pilot study evaluating feasibility and efficacy. Haemophilia (in press).
18. Den Uijl IE, Mauser Bunschoten EP, Roosendaal G, et al. Clinical severity of haemophilia A: Does the classification of the 1950s still stand? Haemophilia 2011; 17: 849-853.
19. Ling M, Heysen JP, Duncan EM, et al. High incidence of ankle arthropathy in mild and moderate haemophilia A. Thromb Haemost 2011; 105: 261-268; Epub 2010/11/09.
20. Lundin B, Ljung R. Pettersson C on behalf of the European Paediatric Network for Haemophilia management. MRI scores of ankles joints in children with haemophilia-Comparison with clinical data. Haemophilia 2005; 11: 116-122.
21. Soreff J, Blomback M. Arthropathy in children with severe hemophilia A. Acta Paediatr Scand 1980; 69: 667-673.
22. Pettersson H, Ahlberg A, Nilsson IM. A radiologic classification of hemophilic arthropathy. Clin Orthop Relat Res 1980; 149: 153-159.
23. Roosendaal G, Lafeber FP. Pathogenesis of haemophilic arthropathy. Haemophilia 2006; 12(Suppl 3): 117-121.
24. Valentino LA. Blood-induced joint disease: The pathophysiology of hemophilic arthropathy. J Thromb Haemost 2010; 8: 1895-1902; Epub 2010/07/01.
25. Roosendaal G, Lafeber FP. Blood-induced joint damage in hemophilia. Semin Thromb Hemost 2003; 29: 37-42.